genes

KLF4

KLF4 is a versatile transcription factor that acts as a bridge between cell growth, differentiation, and the maintenance of stem cell identity. As one of the original Yamanaka factors, it is indispensable for cellular reprogramming, where it helps open the genome and stabilize the pluripotency network. Beyond the embryo, KLF4 is a master regulator of the "phenotypic switching" of vascular smooth muscle cells and is essential for the formation of the skin’s protective barrier and the lining of the gut. In the context of aging, KLF4 plays a dual role: it can act as a tumor suppressor by inducing cell cycle arrest via p21, but its decline in the vasculature is a primary driver of atherosclerosis and arterial stiffness. Its ability to balance proliferation and specialization makes it a key target for regenerative medicine and cardiovascular longevity.

schedule 9 min read update Updated February 27, 2026

Key Takeaways

  • KLF4 is a core Yamanaka factor (OSKM) essential for the induction of pluripotency in adult cells.
  • It serves as a critical 'molecular brake' on the cell cycle by activating p21 (CDKN1A) and inhibiting Cyclin D1.
  • In the arteries, KLF4 prevents the harmful 'phenotypic switching' of smooth muscle cells that leads to plaque formation.
  • It is the primary architect of the skin barrier; without KLF4, mammals die shortly after birth due to rapid dehydration.
  • KLF4 functions as a context-dependent regulator: acting as a tumor suppressor in the gut but an oncogene in certain breast cancers.

Basic Information

Gene Symbol
KLF4
Full Name
Kruppel-Like Factor 4
Also Known As
GKLFEZF
Location
9q31.2
Protein Type
Transcription factor
Protein Family
Kruppel-like factor (KLF) zinc-finger family

Related Isoforms

KLF4

The full-length 470 amino acid protein containing three C-terminal C2H2-type zinc fingers.

Key SNPs

rs10757278 Intergenic (near KLF4)

Strongly associated with coronary artery disease and calcified atherosclerotic plaque in GWAS; KLF4 regulates vascular calcification.

rs2236599 Intronic

Studied for associations with gastric cancer risk and intestinal metaplasia.

Overview

KLF4, or Kruppel-Like Factor 4, is one of the most versatile "decision-makers" in the human genome. It belongs to a family of transcription factors that use specialized "zinc finger" domains to grip onto specific DNA sequences and control the fate of the cell. KLF4 is essentially a molecular gatekeeper that balances two opposing forces: the drive to divide and grow, and the need to specialize and stop. It is found most abundantly in tissues that undergo rapid turnover, such as the skin and the lining of the digestive tract, where it acts as a structural architect and a judge of cellular fitness.

In the history of science, KLF4 is immortalized as the third member of the "Yamanaka cocktail." When scientists were searching for the factors that could turn an adult cell back into a stem cell, KLF4 was the surprise addition. While Oct4 and Sox2 provide the core identity of a stem cell, KLF4 acts as the engine that "opens" the cell’s DNA, allowing those factors to do their work. It is particularly effective at overriding the signals that tell a cell it is old or specialized, making it a cornerstone of modern regenerative medicine.

Beyond its role as a stem cells, KLF4 is a primary guardian of the cardiovascular system. In a healthy artery, KLF4 keeps the smooth muscle cells in a "contractile" state: strong, silent, and focused on maintaining blood pressure. However, as we age or as inflammation builds up, these cells can undergo a "phenotypic switch," turning into aggressive "synthetic" cells that produce inflammation, calcium deposits, and unstable plaques. KLF4 is the primary brake on this process; its presence in the vessel wall is a definitive marker of arterial health.

In the context of longevity, KLF4 serves as a double-edged sword. It is a potent tumor suppressor that can force a damaged cell into "cell cycle arrest" (preventing cancer), but it is also essential for the "plasticity" needed to repair tissues. Without KLF4, we lose our skin’s ability to retain water, our gut’s ability to heal, and our arteries’ ability to resist aging. Understanding how to maintain KLF4 activity in adult tissues is one of the most promising avenues for extending human healthspan and preventing the diseases of late life.

Conceptual Model

A simplified mental model for the pathway:

KLF4
The Circuit Breaker
Stops uncontrolled cell growth to prevent cancer.
Zinc Fingers
The Precision Grip
Allows KLF4 to grab onto specific DNA sequences.
Vascular Wall
The Dam
KLF4 keeps the structure strong and prevents "leaks" (plaque).
Skin Barrier
The Armor
The primary shield that KLF4 builds to protect the body.

KLF4 is a master of multitasking, switching its role entirely depending on which tissue it is in.

Core Health Impacts

  • Cardiovascular Guardian: KLF4 is a critical protector of the arteries. It prevents vascular smooth muscle cells from "switching" into a synthetic state that causes inflammation, vessel hardening, and the buildup of dangerous plaques.
  • Barrier Architect: Without KLF4, life on land would be impossible. It is the primary gene responsible for building the skin’s waterproof barrier and the protective lining of the lungs and intestines.
  • Cell Cycle Sentinel: KLF4 is a potent tumor suppressor that acts as a judge of cellular fitness. It can force damaged or old cells to stop dividing by turning on the p21 "brake," preventing the formation of tumors.
  • Reprogramming Catalyst: As a member of the Yamanaka factors, KLF4 is essential for breaking down the rigid identity of adult cells, allowing them to return to a youthful, pluripotent state for regeneration.
  • DNA Stability Regulator: KLF4 interacts with the p53 pathway to ensure that cells only divide when their genome is intact, acting as a structural guardian of genetic information in rapidly dividing tissues like the gut.

Protein Domains

Zinc Finger Domain

Three C2H2-type zinc fingers at the C-terminus that provide high-affinity binding to GC-rich DNA sequences (BTE motifs).

Proline-Rich Domain

Located at the N-terminus; functions as the primary activation domain to recruit transcriptional co-factors.

Nuclear Localization Signal

A specific sequence that ensures KLF4 is properly imported into the nucleus to regulate gene expression.

Repression Domain

Allows KLF4 to physically block other transcription factors or recruit silencing complexes (like HDACs) to specific genes.

Upstream Regulators

p53 Activator

The master tumor suppressor p53 directly binds to the KLF4 promoter to activate it in response to DNA damage.

STAT3 Activator

In embryonic stem cells, STAT3 (activated by LIF) maintains KLF4 expression to sustain pluripotency.

Oct4 (POU5F1) Activator

Binds to the KLF4 enhancer to reinforce the core pluripotency network.

TGF-beta Activator

Can induce KLF4 expression in various tissues to promote differentiation or inhibit growth.

Inflammatory Cytokines (TNF-alpha) Inhibitor

Chronic inflammation can lead to the downregulation of KLF4 in the vasculature, promoting atherosclerosis.

Downstream Targets

p21 (CDKN1A) Activates

KLF4 is a potent activator of p21, leading to cell cycle arrest and preventing tumor growth.

Cyclin D1 Inhibits

Represses Cyclin D1 to block the G1/S transition of the cell cycle.

Oct4 / Sox2 Activates

During reprogramming, KLF4 binds to the Oct4 and Sox2 promoters to jumpstart the pluripotency circuit.

SM22-alpha Inhibits

In vascular smooth muscle cells, KLF4 represses contractile genes to allow for repair or migration.

Filaggrin Activates

Essential for building the skin barrier; KLF4 ensures the terminal differentiation of keratinocytes.

Role in Aging

KLF4 is a guardian of tissue integrity and vascular youth. Its decline with age is linked to the loss of cellular quality control and the hardening of the arteries.

Vascular Protection

KLF4 prevents vascular smooth muscle cells from turning into "synthetic" cells that promote inflammation and calcification in aging arteries.

Tumor Suppression

By maintaining the p53-KLF4-p21 axis, this gene prevents the survival of damaged cells that could otherwise lead to cancer.

Skin Barrier Integrity

Age-related thinning of the skin and loss of barrier function are linked to reduced KLF4 activity in the epidermis.

Gut Homeostasis

KLF4 regulates the rapid turnover of the intestinal lining; its loss contributes to the development of age-related digestive disorders.

Epigenetic Remodeling

As a reprogramming factor, KLF4 helps clear the "epigenetic noise" that accumulates in aging cells, supporting tissue rejuvenation.

Senescence Modulation

KLF4 can both induce and prevent senescence depending on the cell type, acting as a critical judge of cellular fitness in late life.

Disorders & Diseases

Coronary Artery Disease

Loss of KLF4 in the vasculature promotes the formation of unstable, calcified plaques and increases the risk of heart attack.

Gastric Cancer

KLF4 acts as a major tumor suppressor in the stomach; its loss or silencing is a hallmark of gastric tumor progression.

Loss of Expression: Often occurs via promoter hypermethylation.
Pre-cancerous Marker: KLF4 decline precedes the development of dysplasia.

Breast Cancer

In certain breast cancer subtypes, KLF4 is overexpressed and acts as an oncogene, promoting the survival of cancer stem cells.

Atopic Dermatitis

Reduced KLF4 activity leads to a "leaky" skin barrier, contributing to chronic inflammatory skin conditions and allergies.

Interventions

Supplements

SIRT1 Activators (e.g., Resveratrol)

SIRT1 has been shown to deacetylate KLF4, enhancing its ability to protect the vascular system.

Sulforaphane

Cruciferous vegetable derivative that may support the antioxidant and protective pathways regulated by KLF4.

Vitamin D

Influences skin differentiation and may support KLF4-driven barrier formation.

Lifestyle

Aerobic Exercise

Increases "shear stress" in the blood vessels, which is a potent mechanical activator of KLF4 in the endothelium.

High-Fiber Diet

Supports gut health and the KLF4-mediated maintenance of the intestinal epithelial barrier.

Skin Barrier Protection

Avoiding harsh detergents and using emollients can support the barrier function that KLF4 works to build.

Medicines

Statins

May indirectly support vascular KLF4 levels by reducing inflammation and improving endothelial function.

Yamanaka Factor Gene Therapy

KLF4 is a core component of experimental in vivo reprogramming treatments aimed at tissue rejuvenation.

Lab Tests & Biomarkers

Genetic/Pathology Markers

KLF4 IHC

Used in research and pathology to assess the status of the intestinal lining and tumor suppression.

9q31 Locus Testing

Genetic testing for GWAS-associated SNPs linked to cardiovascular risk.

Functional Tests

Transepidermal Water Loss (TEWL)

Measures skin barrier integrity, which is directly dependent on KLF4 activity.

Hormonal Interactions

Estrogen Vascular Protective

May support KLF4 expression in the blood vessels, contributing to the cardiovascular protection seen in pre-menopausal women.

Glucocorticoids (Cortisol) Complex Modulator

Can influence skin barrier function and KLF4-driven differentiation of keratinocytes.

Deep Dive

Network Diagrams

KLF4 in Vascular Smooth Muscle Phenotypic Switching

KLF4 Cell Cycle Regulation

The Zinc Finger Grip: C2H2 Structural Logic

The ability of KLF4 to control so many different genes lies in its C-terminal DNA-binding domain, which contains three “C2H2-type” zinc fingers. These fingers are among the most precise tools in the cell’s toolkit. Each finger uses a zinc atom to stabilize a small loop of amino acids that can “reach” into the major groove of the DNA double helix.

KLF4 specifically targets “GC-rich” sequences, often referred to as BTE (Basic Transcription Element) motifs. Because these motifs are found in the promoters of thousands of different genes (from cell cycle brakes like p21 to structural proteins like keratin) KLF4 can act as a high-level switchboard, turning on an entire tissue-specific program with a single signal. In reprogramming, this structural precision allows KLF4 to land on “locked” enhancers and recruit the other Yamanaka factors to join it.

Vascular Phenotypic Switching: The Heart of Arterial Aging

Arterial aging is not just a buildup of “junk” in the vessels; it is a change in the identity of the cells within the vessel wall. Vascular smooth muscle cells (VSMCs) are normally specialized for contraction. However, in response to injury or high cholesterol, they can “de-differentiate” into a synthetic, macrophage-like state.

KLF4 is the master regulator of this switch. When KLF4 levels are high, it suppresses the genes that cause VSMCs to migrate and proliferate, keeping the artery wall stable. When KLF4 is lost (often due to chronic inflammation or the buildup of oxidized LDL) the VSMCs lose their identity and begin to produce the fibrous and calcified material that makes up an atherosclerotic plaque. Maintaining KLF4 activity via exercise (which increases mechanical shear stress) is one of the most effective ways to prevent this “aging” of the blood vessels.

The Barrier Guardian: KLF4 in Skin and Gut Integrity

KLF4 is essential for the “barrier function” of the body. In the skin, KLF4 is expressed in the outermost layers (the epidermis), where it tells keratinocytes to stop dividing and start building the waterproof shield of the stratum corneum. Mice born without KLF4 look normal at birth, but they die within hours because they cannot retain water: their skin is effectively “leaky.”

This same logic applies to the gut. The lining of the intestine is one of the most hostile environments in the body, constantly exposed to acid, bacteria, and food particles. KLF4 ensures that the cells of the gut lining differentiate properly into the specialized goblet cells that produce protective mucus. In aging, the decline of KLF4 in the gut leads to a thinner, more permeable lining (often called “leaky gut”), which can drive systemic inflammation and age-related metabolic decline.

The p53-KLF4 Axis: A Judge of Cellular Fitness

KLF4 is a major downstream effector of the “guardian of the genome,” p53. When a cell experiences DNA damage, p53 turns on KLF4. KLF4 then goes to the promoter of the p21 gene (a powerful cell cycle inhibitor) and turns it on, forcing the cell to stop dividing until the damage can be repaired.

This makes KLF4 a critical player in tumor suppression. By stopping the cell cycle, KLF4 prevents the “replication of errors” that leads to cancer. This is why KLF4 is often silenced (via epigenetic methylation) in gastric and colorectal cancers: the tumor must “kill the judge” before it can grow out of control. However, in other contexts like breast cancer, the same KLF4 can act as an oncogene by helping cancer stem cells survive stress, highlighting the incredible context-dependency of this gene.

KLF4 in Reprogramming: Opening the Door to Pluripotency

In the process of creating induced pluripotent stem cells (iPSCs), KLF4 plays a unique role that distinguishes it from Oct4 and Sox2. While the other factors define the “goal” (stemness), KLF4 provides the “means.” It acts as a pioneer factor that can bind to closed, methylated DNA and recruit chromatin-remodeling complexes to “melt” the histone bonds holding the DNA shut.

This “opening” of the genome is the most difficult step of reprogramming. KLF4 works specifically on the enhancers of the Oct4 and Sox2 genes themselves, jumpstarting the core pluripotency loop in a cell that had previously been locked into an adult state. Without KLF4, the reprogramming process is either impossible or incredibly inefficient, making it the essential catalyst for resetting the biological clock of an adult cell.

Relevant Research Papers

Links go to PubMed (abstracts are public); some papers also offer free full text via PMC or the publisher.

Takahashi & Yamanaka (2006) Cell

Identified KLF4 as one of the four essential factors required to reset adult cells to a pluripotent state.

Li et al. (2010) Stem Cells

Established KLF4 as a core regulator of stem cell self-renewal and lineage specification.

Segre et al. (1999) Nature Genetics

The seminal paper showing that KLF4 is the master architect of the skin barrier, essential for terrestrial life.

Yu et al. (2016) Journal of Clinical Investigation

Demonstrated how KLF4 balances lung tissue repair with the prevention of oncogenic transformation.

Yoshida et al. (2008) Arteriosclerosis, Thrombosis, and Vascular Biology

Explained how KLF4 protects arteries by controlling the transition of muscle cells into harmful inflammatory states.

Ghaleb & Yang (2017) Progress in Molecular Biology and Translational Science

Review of KLF4 as a tumor suppressor and its role in maintaining the integrity of the gastrointestinal lining.